The parenteral packaging market was valued at USD 1146 Million in 2021, and it is expected to reach USD 24,973 Million in 2028 with a CAGR of 5.5 % during the forecast period of 2022-2028. Packaging is the main part of the product. Packaging in pharmaceuticals is critical to drug stability. The packaging of pharmaceuticals protects the product from various factors such as moisture, sunlight, and other environmental factors. It, in turn, inhibits microbial development and expands the shelf life of the drug. Parental medicines are dispensed in the body other than oral or rectal. Shared parental drug administration sites are intravenous, intramuscular, or subcutaneous. The parental drug directly administered in the body should be sterile and particle-free, so packaging plays an important role in the parental drugs.
What is Parenteral Products Packaging?
Parenteral packaging is the packaging of sterile outputs created by utilizing one or more additional than one chemical element, which is operated specifically for the packaging of different medicinal liquids utilized in injections and infusions to treat different chronic diseases. The parenteral packaging is accomplished into two dosage types: single and multiple dosages.
Growth Drivers
Growing healthcare expenditure and parenteral industry in emerging economies
The parenteral industry is growing at a rapid pace in emerging economies. Advanced manufacturing methods, technological innovations, and improved integration of organizations have resulted in the industry’s rapid.
Growth. This development of the pharmaceutical industry is pushing the parental packaging market. The growth is expected to be the highest in emerging economies like Brazil, Russia, India, and China. Rising income levels and growing attention to the benefits of good healthcare systems and healthier lifestyles support these countries’ growth. Large population and demographic factors such as the growing young population and higher life expectancy are also the key drivers of this growth.
Increase in Population
An expansion in the aging population and the rising incidence of lifestyle conditions such as diabetes and hypertension has shown an expansion in the utilization of parenteral drugs in both formed and occurring economies. As per the U.S. population Bureau, the aging population was around 50,683,620 in 2016 and is expected to reach 71,453,471 by 2030. The increased prevalence of Alzheimer’s disease and the aging population around the globe are anticipated to select the growth of the parenteral packaging market. According to the World Health Organization, the AD claims worldwide were around 47 million and will reach around 75 million by 2030. the number of patients is forecasted to triple by 2050 due to the high majority rate and shortage of healthcare benefits in rural areas.
Opportunities
Strict Regulation
It Executes stringent restrictions and measures for operating pharmaceutical-grade materials, including glass and plastic. For instance, the World Health Organization (WHO) has developed policies on the packaging of pharmaceutical products, which require to be followed by pharmaceutical associations. Growth in the geriatric population and the rising incidence of lifestyle diseases such as diabetes and hypertension have increased the utilization of parenteral drugs in both developed and emerging economies.
Restraints
Protecting against imitation products
Imitation drugs are created with inaccurate components in improper quantities, which, when consumed, would result in harmful influences such as allergic reactions or sometimes death. Almost half of the imitation drugs are reported in growing economies like China, the Philippines, and Vietnam. Delay in support of new drugs, and they are parental.
Packaging due to the extended product development processes and expenditures results in the improved availability of imitation drugs and faked packaging. These imitation products negatively affect the human body concerning allergic reactions, nausea, vomiting, etc. Defending against these imitation products is a significant challenge for the sector.
Pre Covid-19 Impact on Global Parenteral Products Packaging
Before the covid-19 outbreak, the growth of prefilled syringes will be a driver for the parenteral packaging market in the forecast period. Chemical avoidance of the internal character of glass tubing containers is anticipated to restrain the parenteral packaging market in the forecast period. Implementing ready-to-use glass vials for flexible aseptic filling brings new avenues for the parenteral packaging market. Recycling waste delivered by pharmaceutical packaging is inquiring the parenteral packaging market.
Covid-19 Impact on Global Parenteral Products Packaging
During the Covid-19, the pandemic had negative impacts on the healthcare industry. Deficiency of infrastructure, manpower, disturbances in the supply chain, absence of preparedness, deficiency of important drugs, and many different elements were accountable for the reduction in healthcare industry functioning. The procedures were not vigorous enough to handle such disruptions in the supply chain, infrastructure, manpower, etc. China, a major import destination of medical equipment, healthcare supply chain requirements, and drug formulations, was reeling under the pandemic. It has resulted in the loss of stability in both the healthcare and pharmaceutical sectors. The global medical supply chain is still imbalanced but stabilizes as per the new normal.
Post Covid-19 Impact on Global Parenteral Products Packaging
After the covid-19, Packaging movements were supposed to be necessary during the pandemic. Pharmaceutical packaging businesses profited from this and shared stable revenue growth in 2021. Pharmaceutical packaging companies had improved their productivity to sustain the increased demand for blister packs, vials, prefilled syringes, containers, bottles, cartridges, and pouches. It was largely due to an improved market for Covid-19 related medicines and vaccines. In development, parental packaging for biologics, smart packaging, sterile packaging, patient emphasis packaging, cleanroom expansion, and others would push the market long-term.
By-Products type segmental Analysis
Based on Product type segmental analysis, the market is classified into Bags, Bottles, Ampoules, Vials, Prefilled Syringes and Cartridges. Bottles reached the largest market share amongst other types in the parenteral packaging market. Bottles are the multiple used types of packaging operated for pharmaceutical products. Bottles are appropriate for holding drugs in liquid and solid forms and can be coupled with the necessary cap & closure to suit specific applications such as nasal spray and ophthalmic drops.
By Material segmental Analysis
The market is classified into Glass, Polymer, PVC and Polyolefin. Glass packing has the highest share in the market. They are utilized as packaging material for parenteral products or powders for parenteral use ONLY where suitable stability test data indicates that glass is satisfactory. It is also operated in packaging non-parenteral preparations.
By Regional segmental Analysis
Based on the regional segmental analysis, the market is classified into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. Asia-Pacific monopolizes the parenteral packaging market as in China, the exhibition and consumption of parenteral packaging are growing for the single dosage segment in the region. The Asia-Pacific area is predicted to increase with the highest growth rate in the forecast period of 2022 to 2028 because of increased inventions and expansion in manufacturing products for the single dosage segment, which is one of the significant elements for the development of the parenteral packaging market. Germany is showing the growth of the European parenteral packaging market due to increased health awareness among consumers. The U.S. dominates the North American parenteral packaging market due to more demand for parenteral packaging for the single dosage segment because of shelf-life improvement properties, which has widened its consumption.
Competitors Analysis
The companies include Becton, Dickson and Company, Amcor, Daibochi Plastic, Charter Nex Films, Catalent Inc., Celplast Metalized Products, UDG Healthcare Plc, Prairie State Group, Gerresheimer AG, Schur Flexibles Group and other prominent players in the global parenteral packaging market.
Key Stakeholders
- Market research and consulting firms
- Parenteral Products Packaging Market Associates
- Local Governments
- Regulatory bodies
- Parenteral Products Packaging Market
- Suppliers
- Retailers
- Service Providers
Recent Developments
- In May 2021, Gerresheimer presented a new platform for a body infusion pump, “SensAIR,” to provide high viscosity drugs. It is comfortable to operate and benefits in the self-determination of medication.
- In February 2020, Berry Global presented a new oval tube, extruded, assembled and decorated at a facility in the United States. These oval tubes are suitable for various products other than healthcare, such as beauty and personal care or home care.
- In April 2019, Amcor established a new product designated AmLite Ultra Recyclable. This extreme product is expected to provide the advantage of a reduced carbon footprint. It is unrestricted in different forms, such as pillow pouches, stick packs, and bags. The product is approved for recyclability by the cyclos-HTP Institute.
- In August 2018, Schott declared it is expected to increase the production capacity of polymer syringes with volume size 1–50 ml by 2020. will install This production line in Switzerland. The company will serve the increasing market for polymer syringes through this expansion.
Scope of the Report
Report Attribute |
Details |
Market Size Value in 2021 |
USD 1146 Million |
The revenue forecast in 2028 |
USD 24,973 Million |
Growth Rate |
CAGR of 5.5 % from 2022 to 2028. |
Historical data |
2017 – 2020 |
Forecast period |
2022 – 2028 |
Region covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Key companies Profiled |
The companies include Becton, Dickson and Company, Amcor, Daibochi Plastic,
Charter Nex Films, Catalent Inc., Celplast Metalized Products, UDG Healthcare
Plc, Prairie State Group, Gerresheimer AG, and Schur Flexibles Group are the key players. |
Market Modelling
By Product Type
- Bags
- Bottles
- Ampoules
- Vials
- Prefilled syringes
- Cartridges
By Material
- Glass
- Polymer
- PVC
- Polyolefin
By region
- North America
- Europe
- Asia-Pacific
- The Middle East & Africa
More Related Reports:
UK Childcare Software Market Report
Connected Car Market
Cold Chain Monitoring Market
Global 3D Food Printing Market
Vibrating Microtome Market
Whooping Cough Treatment Market
Viral Vectors Manufacturing Market
Feed Pusher Market
Aluminum Extrusion Market